88 related articles for article (PubMed ID: 10977930)
41. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen.
Cibas ES; Corson JM; Pinkus GS
Hum Pathol; 1987 Jan; 18(1):67-74. PubMed ID: 2434407
[TBL] [Abstract][Full Text] [Related]
42. Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer.
Steger GG; Mader R; Derfler K; Moser K; Dittrich C
Klin Wochenschr; 1989 Aug; 67(16):813-7. PubMed ID: 2796251
[TBL] [Abstract][Full Text] [Related]
43. Antigenic reactivities of purified preparations of carcinoembryonic antigen (CEA) and related normal antigens using four different radioimmunoassay systems for CEA.
Kuroki M; Yamaguchi A; Koga Y; Matsuoka Y
J Immunol Methods; 1983 May; 60(1-2):221-33. PubMed ID: 6406604
[TBL] [Abstract][Full Text] [Related]
44. Production and characterization of monoclonal antibodies against rat tracheal mucins.
Shin CY; Choi EY; Kim KC; Ko KH
Hybridoma; 1998 Jun; 17(3):257-66. PubMed ID: 9708828
[TBL] [Abstract][Full Text] [Related]
45. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
46. DNA vaccine expressing repeated carcinoembryonic antigen (CEA)(625-667) induces strong immunity in mice.
Li D; Hua S; Fan Y; Xu S; Duan X; Liu L; Che Y; Li S; Tan Y
Immunol Lett; 2011 Mar; 135(1-2):124-8. PubMed ID: 21073899
[TBL] [Abstract][Full Text] [Related]
47. Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigen.
Bieglmayer C; Szepesi T; Neunteufel W
Cancer Lett; 1988 Nov; 42(3):199-206. PubMed ID: 2461250
[TBL] [Abstract][Full Text] [Related]
48. Detection of gastric mucins (M1 antigens) in cyst fluid for the diagnosis of cystic lesions of the pancreas.
Hammel PR; Forgue-Lafitte ME; Lévy P; Voitot H; Vilgrain V; Fléjou JF; Molas G; Gespach C; Ruszniewski P; Bernades P; Bara J
Int J Cancer; 1997 Jun; 74(3):286-90. PubMed ID: 9221806
[TBL] [Abstract][Full Text] [Related]
49. Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancer.
LaRue H; Parent-Vaugeois C; Bergeron A; Champetier S; Fradet Y
Int J Cancer; 1997 Jun; 71(6):986-92. PubMed ID: 9185702
[TBL] [Abstract][Full Text] [Related]
50. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
[TBL] [Abstract][Full Text] [Related]
51. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
52. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP
Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322
[TBL] [Abstract][Full Text] [Related]
53. Assay of mucins in human tear fluid.
Spurr-Michaud S; Argüeso P; Gipson I
Exp Eye Res; 2007 May; 84(5):939-50. PubMed ID: 17399701
[TBL] [Abstract][Full Text] [Related]
54. Fractionated radioimmunotherapy with ⁹⁰Y-labeled fully human anti-CEA antibody.
Hanaoka H; Kuroki M; Yamaguchi A; Achmad A; Iida Y; Higuchi T; Oriuchi N; Tsushima Y; Endo K
Cancer Biother Radiopharm; 2014 Mar; 29(2):70-6. PubMed ID: 24299067
[TBL] [Abstract][Full Text] [Related]
55. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
McLaughlin JP; Schlom J; Kantor JA; Greiner JW
Cancer Res; 1996 May; 56(10):2361-7. PubMed ID: 8625312
[TBL] [Abstract][Full Text] [Related]
56. PD-1 Suppresses Development of Humoral Responses That Protect against Tn-Bearing Tumors.
Haro MA; Littrell CA; Yin Z; Huang X; Haas KM
Cancer Immunol Res; 2016 Dec; 4(12):1027-1037. PubMed ID: 27856425
[TBL] [Abstract][Full Text] [Related]
57. Fusion proteins of B7.1 and a carcinoembryonic antigen (CEA)-specific antibody fragment opsonize CEA-expressing tumor cells and coactivate T-cell immunity.
Hoffmann P; Mueller N; Shively JE; Fleischer B; Neumaier M
Int J Cancer; 2001 Jun; 92(5):725-32. PubMed ID: 11340579
[TBL] [Abstract][Full Text] [Related]
58. A carcinoembryonic antigen-directed immunotoxin built by linking a monoclonal antibody to a hemolytic toxin.
Avila AD; Mateo de Acosta C; Lage A
Int J Cancer; 1989 May; 43(5):926-9. PubMed ID: 2785509
[TBL] [Abstract][Full Text] [Related]
59. Comparative evaluation of carcinoembryonic antigen, secretory component, and mucins in index and metachronous adenomas of the colorectum.
Griffioen G; Bosman FT; Verspaget HW; Sier KF; Biemond I; Lamers CB
Gastroenterology; 1991 Oct; 101(4):919-26. PubMed ID: 1889715
[TBL] [Abstract][Full Text] [Related]
60. Liposomal incorporation and immunogenicity of carcinoembryonic antigen.
Phillips NC; Major PP; Ishida M; Sikorska H
J Biol Response Mod; 1987 Dec; 6(6):581-6. PubMed ID: 3450782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
